Carbonic anhydrase III: A neglected isozyme is stepping into the limelight

References

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–4350.
   PubMed Web of Science ®Google Scholar
• Lehtonen J, Shen B, Vihinen M, Casini A, Scozzafava A, Supuran CT et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719–2727.
   PubMed Web of Science ®Google Scholar
• Aspatwar A, Tolvanen ME, Parkkila S. Phylogeny and expression of carbonic anhydrase-related proteins. BMC Mol Biol 2010;11:25.
   PubMed Web of Science ®Google Scholar
• Taniuchi K, Nishimori I, Takeuchi T, Ohtsuki Y, Onishi S. cDNA cloning and developmental expression of murine carbonic anhydrase-related proteins VIII, X, and XI. Brain Res Mol Brain Res 2002;109:207–215.
   PubMedGoogle Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–777.
   PubMed Web of Science ®Google Scholar
• Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995;64:375–401.
   PubMed Web of Science ®Google Scholar
• Parkkila S, Parkkila AK, Rajaniemi H, Shah GN, Grubb JH, Waheed A et al. Expression of membrane-associated carbonic anhydrase XIV on neurons and axons in mouse and human brain. Proc Natl Acad Sci USA 2001;98:1918–1923.
   PubMed Web of Science ®Google Scholar
• Pastoreková S, Parkkila S, Parkkila AK, Opavský R, Zelník V, Saarnio J et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997;112:398–408.
   PubMed Web of Science ®Google Scholar
• Fujikawa-Adachi K, Nishimori I, Taguchi T, Onishi S. Human mitochondrial carbonic anhydrase VB. cDNA cloning, mRNA expression, subcellular localization, and mapping to chromosome x. J Biol Chem 1999;274:21228–21233.
   PubMed Web of Science ®Google Scholar
• Karhumaa P, Leinonen J, Parkkila S, Kaunisto K, Tapanainen J, Rajaniemi H. The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc Natl Acad Sci USA 2001;98:11604–11608.
   PubMed Web of Science ®Google Scholar
• Kivelä J, Parkkila S, Parkkila AK, Rajaniemi H. A low concentration of carbonic anhydrase isoenzyme VI in whole saliva is associated with caries prevalence. Caries Res 1999;33:178–184.
   PubMed Web of Science ®Google Scholar
• Breton S. The cellular physiology of carbonic anhydrases. JOP 2001;2:159–164.
   PubMedGoogle Scholar
• Hilvo M, Rafajová M, Pastoreková S, Pastorek J, Parkkila S. Expression of carbonic anhydrase IX in mouse tissues. J Histochem Cytochem 2004;52:1313–1322.
   PubMedGoogle Scholar
• Parkkila S. Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches. BJU Int 2008;101 Suppl 4:16–21.
   Google Scholar
• Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des 2008;14:649–654.
   PubMed Web of Science ®Google Scholar
• Thiry A, Dogné JM, Supuran CT, Masereel B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 2007;7:855–864.
   PubMed Web of Science ®Google Scholar
• Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S et al. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol Immunother 2011;60:649–658.
   PubMed Web of Science ®Google Scholar
• Jeffery S, Carter ND, Smith A. Immunocytochemical localization of carbonic anhydrase isozymes I, II, and III in rat skeletal muscle. J Histochem Cytochem 1986;34:513–516.
   Google Scholar
• Wade R, Gunning P, Eddy R, Shows T, Kedes L. Nucleotide sequence, tissue-specific expression, and chromosome location of human carbonic anhydrase III: the human CAIII gene is located on the same chromosome as the closely linked CAI and CAII genes. Proc Natl Acad Sci USA 1986;83:9571–9575.
   PubMed Web of Science ®Google Scholar
• Spicer SS, Ge ZH, Tashian RE, Hazen-Martin DJ, Schulte BA. Comparative distribution of carbonic anhydrase isozymes III and II in rodent tissues. Am J Anat 1990;187:55–64.
   PubMedGoogle Scholar
• Stanton LW, Ponte PA, Coleman RT, Snyder MA. Expression of CA III in rodent models of obesity. Mol Endocrinol 1991;5:860–866.
   PubMedGoogle Scholar
• Kelly CD, Carter ND, de Boer P, Jeffery S, Moorman AF, Smith A. Detection of CAIII mRNA in rat skeletal muscle and liver by in situ hybridization. J Histochem Cytochem 1991;39:1243–1247.
   PubMed Web of Science ®Google Scholar
• Carter N, Lönnerholm G, Meyerson B, Wistrand P. Androgen-linked control of carbonic anhydrase III expression occurs in rat perivenous hepatocytes; an immunocytochemical study. Ups J Med Sci 2001;106:67–76.
   PubMed Web of Science ®Google Scholar
• Shiels A, Jeffery S, Wilson C, Carter N. Radioimmunoassay of carbonic anhydrase III in rat tissues. Biochem J 1984;218:281–284.
   PubMed Web of Science ®Google Scholar
• Spicer SS, Ge ZH, Tashian RE, Hazen-Martin DJ, Schulte BA. Comparative distribution of carbonic anhydrase isozymes III and II in rodent tissues. Am J Anat 1990 187(1):55–64.
   Google Scholar
• Kato K, Mokuno K. Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method. Clin Chim Acta 1984;141:169–177.
   PubMed Web of Science ®Google Scholar
• Shima K. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease. Hokkaido Igaku Zasshi 1984;59:98–116.
   Google Scholar
• Väänänen HK, Paloniemi M, Vuori J. Purification and localization of human carbonic anhydrase. III. Typing of skeletal muscle fibers in paraffin embedded sections. Histochemistry 1985;83:231–235.
   PubMedGoogle Scholar
• Zheng A, Rahkila P, Vuori J, Rasi S, Takala T, Väänänen HK. Quantification of carbonic anhydrase III and myoglobin in different fiber types of human psoas muscle. Histochemistry 1992;97:77–81.
   PubMedGoogle Scholar
• Jeffery S, Edwards Y, Carter N. Distribution of CAIII in fetal and adult human tissue. Biochem Genet 1980;18:843–849.
   PubMed Web of Science ®Google Scholar
• Tweedie S, Edwards Y. Mouse carbonic anhydrase III: nucleotide sequence and expression studies. Biochem Genet 1989;27:17–30.
   PubMed Web of Science ®Google Scholar
• Bootorabi F, Jänis J, Hytönen VP, Valjakka J, Kuuslahti M, Vullo D et al. Acetaldehyde-derived modifications on cytosolic human carbonic anhydrases. J Enzyme Inhib Med Chem 2011;26:862–870.
   PubMed Web of Science ®Google Scholar
• Parkkila S, Parkkila AK, Juvonen T, Lehto VP, Rajaniemi H. Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours. Histochem J 1995;27:133–138.
   PubMedGoogle Scholar
• Ruusuvuori E, Li H, Huttu K, Palva JM, Smirnov S, Rivera C et al. Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells. J Neurosci 2004;24:2699–2707.
   PubMed Web of Science ®Google Scholar
• Nógrádi A, Kelly C, Carter ND. Localization of acetazolamide-resistant carbonic anhydrase III in human and rat choroid plexus by immunocytochemistry and in situ hybridisation. Neurosci Lett 1993;151:162–165.
   Google Scholar
• Halmi P, Parkkila S, Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 2006;48:24–30.
   PubMed Web of Science ®Google Scholar
• Syrjälä H, Vuori J, Huttunen K, Väänänen HK. Carbonic anhydrase III as a serum marker for diagnosis of rhabdomyolysis. Clin Chem 1990;36:696.
   PubMed Web of Science ®Google Scholar
• Väänänen HK, Takala TE, Tolonen U, Vuori J, Myllylä VV. Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders. Arch Neurol 1988;45:1254–1256.
   PubMedGoogle Scholar
• Väänänen HK, Syrjälä H, Rahkila P, Vuori J, Melamies LM, Myllylä V et al. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. Clin Chem 1990;36:635–638.
   PubMed Web of Science ®Google Scholar
• Beuerle JR, Azzazy HM, Styba G, Duh SH, Christenson RH. Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. Clin Chim Acta 2000;294:115–128.
   PubMed Web of Science ®Google Scholar
• Vuotikka P, Uusimaa P, Niemelä M, Väänänen K, Vuori J, Peuhkurinen K. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. Int J Cardiol 2003;91:137–144.
   PubMed Web of Science ®Google Scholar
• Tu C, Chen X, Ren X, LoGrasso PV, Jewell DA, Laipis PJ et al. Interactions of active-site residues and catalytic activity of human carbonic anhydrase III. J Biol Chem 1994;269:23002–23006.
   PubMedGoogle Scholar
• Carter N, Jeffery S, Shiels A, Edwards Y, Tipler T, Hopkinson DA. Characterization of human carbonic anhydrase III from skeletal muscle. Biochem Genet 1979;17:837–854.
   PubMed Web of Science ®Google Scholar
• An H, Tu C, Ren K, Laipis PJ, Silverman DN. Proton transfer within the active-site cavity of carbonic anhydrase III. Biochim Biophys Acta 2002;1599:21–27.
   PubMedGoogle Scholar
• Elder I, Fisher Z, Laipis PJ, Tu C, McKenna R, Silverman DN. Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase III. Proteins 2007;68:337–343.
   PubMed Web of Science ®Google Scholar
• Duda DM, Tu C, Fisher SZ, An H, Yoshioka C, Govindasamy L et al. Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer. Biochemistry 2005;44:10046–10053.
   PubMed Web of Science ®Google Scholar
• LoGrasso PV, Tu C, Chen X, Taoka S, Laipis PJ, Silverman DN. Influence of amino acid replacement at position 198 on catalytic properties of zinc-bound water in human carbonic anhydrase III. Biochemistry 1993;32:5786–5791.
   PubMed Web of Science ®Google Scholar
• Koester MK, Pullan LM, Noltmann EA. The p-nitrophenyl phosphatase activity of muscle carbonic anhydrase. Arch Biochem Biophys 1981;211:632–642.
   PubMed Web of Science ®Google Scholar
• Kim G, Selengut J, Levine RL. Carbonic anhydrase III: the phosphatase activity is extrinsic. Arch Biochem Biophys 2000;377:334–340.
   PubMed Web of Science ®Google Scholar
• Truppo E, Supuran CT, Sandomenico A, Vullo D, Innocenti A, Di Fiore A et al. Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors. Bioorg Med Chem Lett 2012;22:1560–1564.
   PubMed Web of Science ®Google Scholar
• Kim G, Lee TH, Wetzel P, Geers C, Robinson MA, Myers TG et al. Carbonic anhydrase III is not required in the mouse for normal growth, development, and life span. Mol Cell Biol 2004;24:9942–9947.
   PubMed Web of Science ®Google Scholar
• Liu M, Walter GA, Pathare NC, Forster RE, Vandenborne K. A quantitative study of bioenergetics in skeletal muscle lacking carbonic anhydrase III using 31P magnetic resonance spectroscopy. Proc Natl Acad Sci USA 2007;104:371–376.
   PubMed Web of Science ®Google Scholar
• Alver A, Uçar F, Keha EE, Kalay E, Ovali E. Effects of leptin and insulin on CA III expression in rat adipose tissue. J Enzyme Inhib Med Chem 2004;19:279–281.
   PubMed Web of Science ®Google Scholar
• Räisänen SR, Lehenkari P, Tasanen M, Rahkila P, Härkönen PL, Väänänen HK. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J 1999;13:513–522.
   PubMed Web of Science ®Google Scholar
• Zimmerman UJ, Wang P, Zhang X, Bogdanovich S, Forster R. Anti-oxidative response of carbonic anhydrase III in skeletal muscle. IUBMB Life 2004;56:343–347.
   PubMed Web of Science ®Google Scholar
• Mallis RJ, Poland BW, Chatterjee TK, Fisher RA, Darmawan S, Honzatko RB et al. Crystal structure of S-glutathiolated carbonic anhydrase III. FEBS Lett 2000;482:237–241.
   PubMed Web of Science ®Google Scholar
• Mallis RJ, Hamann MJ, Zhao W, Zhang T, Hendrich S, Thomas JA. Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats. Biol Chem 2002;383:649–662.
   PubMed Web of Science ®Google Scholar
• Kuo WH, Chiang WL, Yang SF, Yeh KT, Yeh CM, Hsieh YS et al. The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. Life Sci 2003;73:2211–2223.
   PubMedGoogle Scholar
• Dai HY, Hong CC, Liang SC, Yan MD, Lai GM, Cheng AL et al. Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway. Mol Carcinog 2008;47:956–963.
   PubMed Web of Science ®Google Scholar
• Robert-Pachot M, Desbos A, Moreira A, Becchi M, Tebib J, Bonnin M et al. Carbonic anhydrase III: a new target for autoantibodies in autoimmune diseases. Autoimmunity 2007;40:380–389.
   PubMed Web of Science ®Google Scholar
• Du AL, Ren HM, Lu CZ, Tu JL, Xu CF, Sun YA. Carbonic anhydrase III is insufficient in muscles of myasthenia gravis patients. Autoimmunity 2009;42:209–215.
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Scozzafava A, Supuran CT. Carbonic anhydrase activators: Activation of the human cytosolic isozyme III and membrane-associated isoform IV with amino acids and amines. Bioorg Med Chem Lett 2008;18:4303–4307.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12:7057–7066.
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, Scozzafava A, Kaila K, Supuran CT. Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines. Bioorg Med Chem Lett 2007;17:4107–4112.
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. Bioorg Med Chem Lett 2007;17:1336–1340.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Onishi S, Vullo D, Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines. Bioorg Med Chem 2007;15:5351–5357.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Vullo D, Nishimori I, Scozzafava A, Pastorek J, Supuran CT. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg Med Chem 2008;16:3530–3536.
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17:628–635.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Puccetti L, Supuran CT. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15:5136–5141.
   PubMed Web of Science ®Google Scholar
• Biswas S, Aggarwal M, Güzel Ö, Scozzafava A, McKenna R, Supuran CT. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. Bioorg Med Chem 2011;19:3732–3738.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem 2007;15:7229–7236.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett 2009;19:1855–1857.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. J Enzyme Inhib Med Chem 2009;24:70–76.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A. Designing of novel carbonic anhydrase inhibitors and activators. Curr Med Chem Cardiovasc Hematol Agents 2004;2:49–68.
   PubMedGoogle Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs 2012;17:11–15.
   PubMed Web of Science ®Google Scholar